What options are available when considering starting insulin: premix or basal?

Diabetes technology & therapeutics

Volumn 13 Suppl 1, Issue , 2011, Pages

  Lavernia, Frank ^a  

^a North Broward Diabetes Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BASAL INSULIN; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

BLOOD; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DRUG ADMINISTRATION; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

CLINICAL TRIALS AS TOPIC; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

MLCS; MLOWN;

EID: 80054083753     PISSN: None     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2010.0248     Document Type: Review

References (0)